Katherine Jackman

Katherine Jackman currently serves as a Board Observer at AstronauTx and NRG Therapeutics, alongside the role of Non Executive Director at NRG Therapeutics. Katherine has been an Investment Manager at Brandon Capital Partners since November 2016, and concurrently holds Board Observer positions at Allay Therapeutics and previously at Azura Ophthalmics Limited. Earlier experience includes serving as Chief Operating Officer at Athena Medicines Pty Ltd and a Research Fellow at The Florey Institute of Neuroscience and Mental Health. Academic credentials include a Doctor of Philosophy in Pharmacology from the University of Melbourne, where Katherine also earned a Bachelor of Science (Honours) in the same field, as well as an MBA from Melbourne Business School and a Company Directors Course from the Australian Institute of Company Directors.